These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8385284)

  • 1. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA; Cowan P; Patrick AW; Clarke BF
    Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW; Klein F; Christensen PD; Sørensen K; Andersen PH; Møller J; Pedersen EB; Christiansen JS; Mogensen CE
    Diabete Metab; 1994; 20(5):485-93. PubMed ID: 7859897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus.
    Bilo H; Kluitman E; van Ballegooie E; Potter van Loon BJ; Bakker K; Michels B; Gans R; Donker A
    Diabetes Res; 1993; 23(3):115-22. PubMed ID: 7712685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal haemodynamics during short-term angiotensin converting enzyme inhibition in normotensive normoalbuminuric insulin dependent diabetics.
    Vora JP; Hendre TJ; Atiea J; Owens DR
    Diabetes Res; 1989 May; 11(1):9-12. PubMed ID: 2695280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP; Raskovic M; Schimke E
    Dtsch Med Wochenschr; 1994 Jun; 119(22):796-800. PubMed ID: 8205941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
    Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of acute angiotensin converting enzyme inhibitors and calcium antagonists in transplant renal artery stenosis.
    Mourad G; Ribstein J; Argiles A; Mimran A; Mion C
    Nephrol Dial Transplant; 1989; 4(1):66-70. PubMed ID: 2494601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
    Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R; Malý J; Simková R
    Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y; Tharaux PL; Ragueneau I; Dussaule JC; Picker JL; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Captopril + hydrochlorothiazide versus captopril + nifedipine in the treatment of arterial hypertension in diabetes mellitus type II].
    Souvirón Rodríguez A; Martínez Morillo M
    Rev Esp Cardiol; 1992; 45(7):432-7. PubMed ID: 1439067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.